Icares Medicus Valuation
| 6612 Stock | TWD 125.50 1.00 0.79% |
At this time, the firm appears to be overvalued. Icares Medicus retains a regular Real Value of NT$113.19 per share. The prevalent price of the firm is NT$125.5. Our model calculates the value of Icares Medicus from evaluating the firm fundamentals such as Return On Asset of 0.0835, return on equity of 0.13, and Current Valuation of 2.39 B as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Icares Medicus' price fluctuation is very steady at this time. Calculation of the real value of Icares Medicus is based on 3 months time horizon. Increasing Icares Medicus' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Icares stock is determined by what a typical buyer is willing to pay for full or partial control of Icares Medicus. Since Icares Medicus is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Icares Stock. However, Icares Medicus' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 125.5 | Real 113.19 | Hype 125.5 | Naive 115.28 |
The intrinsic value of Icares Medicus' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Icares Medicus' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Icares Medicus helps investors to forecast how Icares stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Icares Medicus more accurately as focusing exclusively on Icares Medicus' fundamentals will not take into account other important factors: Icares Medicus Total Value Analysis
Icares Medicus is presently anticipated to have takeover price of 2.39 B with market capitalization of 4.36 B, debt of 2.8 M, and cash on hands of 301 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Icares Medicus fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.39 B | 4.36 B | 2.8 M | 301 M |
Icares Medicus Investor Information
About 54.0% of the company shares are owned by insiders or employees . The book value of Icares Medicus was presently reported as 25.38. The company last dividend was issued on the 7th of April 2022. Icares Medicus had 1000:1100 split on the 7th of July 2024. Based on the key indicators related to Icares Medicus' liquidity, profitability, solvency, and operating efficiency, Icares Medicus is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Icares Medicus Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Icares Medicus has an asset utilization ratio of 40.78 percent. This indicates that the Company is making NT$0.41 for each dollar of assets. An increasing asset utilization means that Icares Medicus is more efficient with each dollar of assets it utilizes for everyday operations.Icares Medicus Ownership Allocation
Icares Medicus has a total of 34.16 Million outstanding shares. Icares Medicus secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Icares Medicus Profitability Analysis
The company reported the revenue of 393.92 M. Net Income was 58.6 M with profit before overhead, payroll, taxes, and interest of 322.88 M.About Icares Medicus Valuation
Our relative valuation model uses a comparative analysis of Icares Medicus. We calculate exposure to Icares Medicus's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Icares Medicus's related companies.ICARES Medicus, Inc. engages in the research and development, manufacture, and sale of ophthalmic medical materials. The company was founded in 2011 and is based in Zhubei, Taiwan. ICARES MEDICUS is traded on Taiwan OTC Exchange in Taiwan.
8 Steps to conduct Icares Medicus' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Icares Medicus' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Icares Medicus' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Icares Medicus' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Icares Medicus' revenue streams: Identify Icares Medicus' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Icares Medicus' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Icares Medicus' growth potential: Evaluate Icares Medicus' management, business model, and growth potential.
- Determine Icares Medicus' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Icares Medicus' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Icares Stock Analysis
When running Icares Medicus' price analysis, check to measure Icares Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icares Medicus is operating at the current time. Most of Icares Medicus' value examination focuses on studying past and present price action to predict the probability of Icares Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icares Medicus' price. Additionally, you may evaluate how the addition of Icares Medicus to your portfolios can decrease your overall portfolio volatility.